Skip to main content
Erschienen in: Heart and Vessels 3/2023

17.10.2022 | Original Article

Characterization of baseline clinical factors associated with incident worsening kidney function in patients with non-valvular atrial fibrillation: the Hokuriku-Plus AF Registry

verfasst von: Kenshi Hayashi, Yoshihiro Tanaka, Toyonobu Tsuda, Akihiro Nomura, Noboru Fujino, Hiroshi Furusho, Norihiko Sakai, Yasunori Iwata, Soichiro Usui, Kenji Sakata, Takeshi Kato, Hayato Tada, Takashi Kusayama, Keisuke Usuda, Masa-aki Kawashiri, Rod S. Passman, Takashi Wada, Masakazu Yamagishi, Masayuki Takamura, the Hokuriku-Plus AF Registry Investigators

Erschienen in: Heart and Vessels | Ausgabe 3/2023

Einloggen, um Zugang zu erhalten

Abstract

Evidence suggests that atrial fibrillation (AF) could increase the risk of worsening kidney function (WKF) which is linked to an increased risk of stroke, bleeding, and death in AF patients. However, limited data exist regarding the factors that could lead to WKF in these patients. Therefore, we sought to identify the potential factors associated with the development of WKF in patients with non-valvular AF (NVAF). We analyzed prospectively recruited 1122 NVAF patients [men 71.9%, median age 73.0 years (interquartile range: 66.0–79.0)] with a baseline estimated glomerular filtration rate (eGFR) ≥ 15 mL/min/1.73 m2 from the Hokuriku-Plus AF Registry. The primary outcome was incident WKF, defined as the %eGFR change from the baseline ≥ 30% during the follow-up period. We evaluated the association between baseline variables and incident WKF using univariate and multivariate Cox proportional hazard models. We also evaluated the non-linear association between the identified factors and incident WKF. During a median follow-up period of 3.0 years (interquartile range: 2.7–3.3), incident WKF was observed in 108 patients (32.6 per 1000 person-years). Compared to the patients without incident WKF, the patients with incident WKF were older and had a higher prevalence of heart failure (HF), diabetes mellitus (DM), and vascular disease at baseline. Those who experienced incident WKF also had higher diastolic blood pressure, lower hemoglobin, lower eGFR, higher B-type natriuretic peptide (BNP) and used warfarin more frequently. Upon multivariate analysis, age ≥ 75 years, HF, DM, and anemia were independently associated with incident WKF. Additionally, age and hemoglobin were linearly associated with the risk of incident WKF, whereas a J- or U-shaped association was observed for HbA1c and BNP. Age ≥ 75 years, HF, DM, and anemia were associated with the development of WKF in Japanese patients with NVAF. In patients with these risk factors, a careful monitoring of the kidney function and appropriate interventions may be important when possible.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22:983–988CrossRef Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22:983–988CrossRef
2.
Zurück zum Zitat Hayashi K, Tsuda T, Nomura A, Fujino N, Nohara A, Sakata K, Konno T, Nakanishi C, Tada H, Nagata Y, Teramoto R, Tanaka Y, Kawashiri MA, Yamagishi M, Hokuriku-Plus AFRI (2018) Impact of B-type natriuretic peptide level on risk stratification of thromboembolism and death in patients with nonvalvular atrial fibrillation-the Hokuriku-plus AF registry. Circ J 82:1271–1278CrossRef Hayashi K, Tsuda T, Nomura A, Fujino N, Nohara A, Sakata K, Konno T, Nakanishi C, Tada H, Nagata Y, Teramoto R, Tanaka Y, Kawashiri MA, Yamagishi M, Hokuriku-Plus AFRI (2018) Impact of B-type natriuretic peptide level on risk stratification of thromboembolism and death in patients with nonvalvular atrial fibrillation-the Hokuriku-plus AF registry. Circ J 82:1271–1278CrossRef
3.
Zurück zum Zitat Tanaka Y, Shah NS, Passman R, Greenland P, Lloyd-Jones DM, Khan SS (2021) Trends in cardiovascular mortality related to atrial fibrillation in the United States, 2011 to 2018. J Am Heart Assoc 10:e020163CrossRef Tanaka Y, Shah NS, Passman R, Greenland P, Lloyd-Jones DM, Khan SS (2021) Trends in cardiovascular mortality related to atrial fibrillation in the United States, 2011 to 2018. J Am Heart Assoc 10:e020163CrossRef
4.
Zurück zum Zitat Usuda K, Kato T, Tsuda T, Tada H, Niwa S, Usui S, Sakata K, Hayashi K, Furusho H, Kawashiri M, Takamura M, Otsuka T, Suzuki S, Hirata A, Murakami M, Takami M, Kimura M, Fukaya H, Nakahara S, Shimizu W, Iwasaki YK, Hayashi H, Harada T, Nakajima I, Okumura K, Koyama J, Tokuda M, Yamane T, Momiyama Y, Tanimoto K, Soejima K, Nonoguchi N, Ejima K, Hagiwara N, Harada M, Sonoda K, Inoue M, Kumagai K, Hayashi H, Satomi K, Yazaki Y, Watari Y, Arai M, Watanabe R, Yokoyama K, Matsumoto N, Nagashima K, Okumura Y, on behalf of the AFAFR (2022) Impact of sinus rhythm maintenance on major adverse cardiac and cerebrovascular events after catheter ablation of atrial fibrillation: insights from AF frontier ablation registry. Heart Vessels 37:327–336CrossRef Usuda K, Kato T, Tsuda T, Tada H, Niwa S, Usui S, Sakata K, Hayashi K, Furusho H, Kawashiri M, Takamura M, Otsuka T, Suzuki S, Hirata A, Murakami M, Takami M, Kimura M, Fukaya H, Nakahara S, Shimizu W, Iwasaki YK, Hayashi H, Harada T, Nakajima I, Okumura K, Koyama J, Tokuda M, Yamane T, Momiyama Y, Tanimoto K, Soejima K, Nonoguchi N, Ejima K, Hagiwara N, Harada M, Sonoda K, Inoue M, Kumagai K, Hayashi H, Satomi K, Yazaki Y, Watari Y, Arai M, Watanabe R, Yokoyama K, Matsumoto N, Nagashima K, Okumura Y, on behalf of the AFAFR (2022) Impact of sinus rhythm maintenance on major adverse cardiac and cerebrovascular events after catheter ablation of atrial fibrillation: insights from AF frontier ablation registry. Heart Vessels 37:327–336CrossRef
5.
Zurück zum Zitat Watanabe H, Watanabe T, Sasaki S, Nagai K, Roden DM, Aizawa Y (2009) Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study. Am Heart J 158:629–636CrossRef Watanabe H, Watanabe T, Sasaki S, Nagai K, Roden DM, Aizawa Y (2009) Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study. Am Heart J 158:629–636CrossRef
6.
Zurück zum Zitat Staerk L, Sherer JA, Ko D, Benjamin EJ, Helm RH (2017) Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes. Circ Res 120:1501–1517CrossRef Staerk L, Sherer JA, Ko D, Benjamin EJ, Helm RH (2017) Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes. Circ Res 120:1501–1517CrossRef
7.
Zurück zum Zitat Grogan M, Smith HC, Gersh BJ, Wood DL (1992) Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol 69:1570–1573CrossRef Grogan M, Smith HC, Gersh BJ, Wood DL (1992) Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol 69:1570–1573CrossRef
8.
Zurück zum Zitat Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, Carnes CA, Bauer JA, Tchou PJ, Niebauer MJ, Natale A, Van Wagoner DR (2001) C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 104:2886–2891CrossRef Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, Carnes CA, Bauer JA, Tchou PJ, Niebauer MJ, Natale A, Van Wagoner DR (2001) C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 104:2886–2891CrossRef
9.
Zurück zum Zitat Dudley SC Jr, Hoch NE, McCann LA, Honeycutt C, Diamandopoulos L, Fukai T, Harrison DG, Dikalov SI, Langberg J (2005) Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases. Circulation 112:1266–1273CrossRef Dudley SC Jr, Hoch NE, McCann LA, Honeycutt C, Diamandopoulos L, Fukai T, Harrison DG, Dikalov SI, Langberg J (2005) Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases. Circulation 112:1266–1273CrossRef
10.
Zurück zum Zitat Bansal N, Xie D, Tao K, Chen J, Deo R, Horwitz E, Hsu CY, Kallem RK, Keane MG, Lora CM, Raj D, Soliman EZ, Strauss L, Wolf M, Go AS, Study C (2016) Atrial fibrillation and risk of ESRD in adults with CKD. Clin J Am Soc Nephrol 11:1189–1196CrossRef Bansal N, Xie D, Tao K, Chen J, Deo R, Horwitz E, Hsu CY, Kallem RK, Keane MG, Lora CM, Raj D, Soliman EZ, Strauss L, Wolf M, Go AS, Study C (2016) Atrial fibrillation and risk of ESRD in adults with CKD. Clin J Am Soc Nephrol 11:1189–1196CrossRef
11.
Zurück zum Zitat Tanaka Y, Tada H, Hara S, Hayashi K, Patel RB, Nishikawa T, Hashiba A, Takamura M, Greenland P, Kawashiri MA (2021) Association of proteinuria with incident atrial fibrillation in the general Japanese population. J Cardiol 77:100–105CrossRef Tanaka Y, Tada H, Hara S, Hayashi K, Patel RB, Nishikawa T, Hashiba A, Takamura M, Greenland P, Kawashiri MA (2021) Association of proteinuria with incident atrial fibrillation in the general Japanese population. J Cardiol 77:100–105CrossRef
12.
Zurück zum Zitat Molnar AO, Eddeen AB, Ducharme R, Garg AX, Harel Z, McCallum MK, Perl J, Wald R, Zimmerman D, Sood MM (2017) Association of proteinuria and incident atrial fibrillation in patients with intact and reduced kidney function. J Am Heart Assoc 6:e005685CrossRef Molnar AO, Eddeen AB, Ducharme R, Garg AX, Harel Z, McCallum MK, Perl J, Wald R, Zimmerman D, Sood MM (2017) Association of proteinuria and incident atrial fibrillation in patients with intact and reduced kidney function. J Am Heart Assoc 6:e005685CrossRef
13.
Zurück zum Zitat Kulkarni N, Gukathasan N, Sartori S, Baber U (2012) Chronic kidney disease and atrial fibrillation: a contemporary overview. J Atr Fibrillation 5:448 Kulkarni N, Gukathasan N, Sartori S, Baber U (2012) Chronic kidney disease and atrial fibrillation: a contemporary overview. J Atr Fibrillation 5:448
14.
Zurück zum Zitat Reinecke H, Brand E, Mesters R, Schabitz WR, Fisher M, Pavenstadt H, Breithardt G (2009) Dilemmas in the management of atrial fibrillation in chronic kidney disease. J Am Soc Nephrol 20:705–711CrossRef Reinecke H, Brand E, Mesters R, Schabitz WR, Fisher M, Pavenstadt H, Breithardt G (2009) Dilemmas in the management of atrial fibrillation in chronic kidney disease. J Am Soc Nephrol 20:705–711CrossRef
15.
Zurück zum Zitat Olesen JB, Lip GY, Kamper AL, Hommel K, Kober L, Lane DA, Lindhardsen J, Gislason GH, Torp-Pedersen C (2012) Stroke and bleeding in atrial fibrillation with chronic kidney disease. N Engl J Med 367:625–635CrossRef Olesen JB, Lip GY, Kamper AL, Hommel K, Kober L, Lane DA, Lindhardsen J, Gislason GH, Torp-Pedersen C (2012) Stroke and bleeding in atrial fibrillation with chronic kidney disease. N Engl J Med 367:625–635CrossRef
16.
Zurück zum Zitat Bonde AN, Lip GY, Kamper AL, Fosbol EL, Staerk L, Carlson N, Torp-Pedersen C, Gislason G, Olesen JB (2016) Renal function and the risk of stroke and bleeding in patients with atrial fibrillation: an observational cohort study. Stroke 47:2707–2713CrossRef Bonde AN, Lip GY, Kamper AL, Fosbol EL, Staerk L, Carlson N, Torp-Pedersen C, Gislason G, Olesen JB (2016) Renal function and the risk of stroke and bleeding in patients with atrial fibrillation: an observational cohort study. Stroke 47:2707–2713CrossRef
17.
Zurück zum Zitat Boriani G, Laroche C, Diemberger I, Popescu MI, Rasmussen LH, Petrescu L, Crijns H, Tavazzi L, Maggioni AP, Lip GYH (2016) Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes. Sci Rep 6:30271CrossRef Boriani G, Laroche C, Diemberger I, Popescu MI, Rasmussen LH, Petrescu L, Crijns H, Tavazzi L, Maggioni AP, Lip GYH (2016) Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes. Sci Rep 6:30271CrossRef
18.
Zurück zum Zitat Abe M, Ogawa H, Ishii M, Masunaga N, Esato M, Chun YH, Tsuji H, Wada H, Hasegawa K, Lip GY, Akao M (2017) Relation of stroke and major bleeding to creatinine clearance in patients with atrial fibrillation (from the Fushimi AF registry). Am J Cardiol 119:1229–1237CrossRef Abe M, Ogawa H, Ishii M, Masunaga N, Esato M, Chun YH, Tsuji H, Wada H, Hasegawa K, Lip GY, Akao M (2017) Relation of stroke and major bleeding to creatinine clearance in patients with atrial fibrillation (from the Fushimi AF registry). Am J Cardiol 119:1229–1237CrossRef
19.
Zurück zum Zitat Kodani E, Atarashi H, Inoue H, Okumura K, Yamashita T, Origasa H, Investigators JRR (2018) Impact of creatinine clearance on outcomes in patients with non-valvular atrial fibrillation: a subanalysis of the J-RHYTHM registry. Eur Heart J Qual Care Clin Outcomes 4:59–68CrossRef Kodani E, Atarashi H, Inoue H, Okumura K, Yamashita T, Origasa H, Investigators JRR (2018) Impact of creatinine clearance on outcomes in patients with non-valvular atrial fibrillation: a subanalysis of the J-RHYTHM registry. Eur Heart J Qual Care Clin Outcomes 4:59–68CrossRef
20.
Zurück zum Zitat Mitsuma W, Matsubara T, Hatada K, Imai S, Saito N, Shimada H, Miyazaki S (2016) Clinical characteristics of hemodialysis patients with atrial fibrillation: the RAKUEN (registry of atrial fibrillation in chronic kidney disease under hemodialysis from Niigata) study. J Cardiol 68:148–155CrossRef Mitsuma W, Matsubara T, Hatada K, Imai S, Saito N, Shimada H, Miyazaki S (2016) Clinical characteristics of hemodialysis patients with atrial fibrillation: the RAKUEN (registry of atrial fibrillation in chronic kidney disease under hemodialysis from Niigata) study. J Cardiol 68:148–155CrossRef
21.
Zurück zum Zitat Yamashita Y, Takagi D, Hamatani Y, Iguchi M, Masunaga N, Esato M, Chun YH, Itoh H, Nishimura M, Wada H, Hasegawa K, Ogawa H, Abe M, Akao M (2016) Clinical characteristics and outcomes of dialysis patients with atrial fibrillation: the Fushimi AF Registry. Heart Vessels 31:2025–2034CrossRef Yamashita Y, Takagi D, Hamatani Y, Iguchi M, Masunaga N, Esato M, Chun YH, Itoh H, Nishimura M, Wada H, Hasegawa K, Ogawa H, Abe M, Akao M (2016) Clinical characteristics and outcomes of dialysis patients with atrial fibrillation: the Fushimi AF Registry. Heart Vessels 31:2025–2034CrossRef
22.
Zurück zum Zitat Zhang L, Steckman DA, Adelstein EC, Schulman-Marcus J, Loka A, Mathew RO, Venditti FJ, Sidhu MS (2019) Oral anticoagulation for atrial fibrillation thromboembolism prophylaxis in the chronic kidney disease population: the state of the art in 2019. Cardiovasc Drugs Ther 33:481–488CrossRef Zhang L, Steckman DA, Adelstein EC, Schulman-Marcus J, Loka A, Mathew RO, Venditti FJ, Sidhu MS (2019) Oral anticoagulation for atrial fibrillation thromboembolism prophylaxis in the chronic kidney disease population: the state of the art in 2019. Cardiovasc Drugs Ther 33:481–488CrossRef
23.
Zurück zum Zitat Fanola CL, Mooney D, Cowan AJ, Ko D, Sisson EK, Henault LE, Tripodis Y, Hylek EM (2017) Incidence of severe renal dysfunction among individuals taking warfarin and implications for non-vitamin K oral anticoagulants. Am Heart J 184:150–155CrossRef Fanola CL, Mooney D, Cowan AJ, Ko D, Sisson EK, Henault LE, Tripodis Y, Hylek EM (2017) Incidence of severe renal dysfunction among individuals taking warfarin and implications for non-vitamin K oral anticoagulants. Am Heart J 184:150–155CrossRef
24.
Zurück zum Zitat Tsuda T, Hayashi K, Fujino N, Konno T, Tada H, Nomura A, Tanaka Y, Sakata K, Furusho H, Takamura M, Kawashiri MA, Yamagishi M, Hokuriku-Plus AFRI (2019) Effect of hypertrophic cardiomyopathy on the prediction of thromboembolism in patients with nonvalvular atrial fibrillation. Heart Rhythm 16:829–837CrossRef Tsuda T, Hayashi K, Fujino N, Konno T, Tada H, Nomura A, Tanaka Y, Sakata K, Furusho H, Takamura M, Kawashiri MA, Yamagishi M, Hokuriku-Plus AFRI (2019) Effect of hypertrophic cardiomyopathy on the prediction of thromboembolism in patients with nonvalvular atrial fibrillation. Heart Rhythm 16:829–837CrossRef
25.
Zurück zum Zitat Yamagishi M, Tsuda T, Kato T, Furusho H, Hayashi K, Hokuriku-plus AFRRG (2019) Cost-effectiveness for prevention of thromboembolism by anticoagulants in non-valvular atrial fibrillation: additional analysis from the Hokuriku-Plus AF Registry. Heart Vessels 34:1024–1030CrossRef Yamagishi M, Tsuda T, Kato T, Furusho H, Hayashi K, Hokuriku-plus AFRRG (2019) Cost-effectiveness for prevention of thromboembolism by anticoagulants in non-valvular atrial fibrillation: additional analysis from the Hokuriku-Plus AF Registry. Heart Vessels 34:1024–1030CrossRef
26.
Zurück zum Zitat Japanese Society of Nephrology (2012) Special issue: clinical practice guidebook for diagnosis and treatment of chronic kidney disease 2012. Nihon Jinzo Gakkai Shi 54(8):1034–1191 Japanese Society of Nephrology (2012) Special issue: clinical practice guidebook for diagnosis and treatment of chronic kidney disease 2012. Nihon Jinzo Gakkai Shi 54(8):1034–1191
27.
Zurück zum Zitat WHO (1968) Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser 405:5–37 WHO (1968) Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser 405:5–37
28.
Zurück zum Zitat Matsushita K, Chen J, Sang Y, Ballew SH, Shimazaki R, Fukagawa M, Imai E, Coresh J, Hishida A (2016) Risk of end-stage renal disease in Japanese patients with chronic kidney disease increases proportionately to decline in estimated glomerular filtration rate. Kidney Int 90:1109–1114CrossRef Matsushita K, Chen J, Sang Y, Ballew SH, Shimazaki R, Fukagawa M, Imai E, Coresh J, Hishida A (2016) Risk of end-stage renal disease in Japanese patients with chronic kidney disease increases proportionately to decline in estimated glomerular filtration rate. Kidney Int 90:1109–1114CrossRef
29.
Zurück zum Zitat Kanda E, Usui T, Kashihara N, Iseki C, Iseki K, Nangaku M (2018) Importance of glomerular filtration rate change as surrogate endpoint for the future incidence of end-stage renal disease in general Japanese population: community-based cohort study. Clin Exp Nephrol 22:318–327CrossRef Kanda E, Usui T, Kashihara N, Iseki C, Iseki K, Nangaku M (2018) Importance of glomerular filtration rate change as surrogate endpoint for the future incidence of end-stage renal disease in general Japanese population: community-based cohort study. Clin Exp Nephrol 22:318–327CrossRef
30.
Zurück zum Zitat Yao X, Tangri N, Gersh BJ, Sangaralingham LR, Shah ND, Nath KA, Noseworthy PA (2017) Renal outcomes in anticoagulated patients with atrial fibrillation. J Am Coll Cardiol 70:2621–2632CrossRef Yao X, Tangri N, Gersh BJ, Sangaralingham LR, Shah ND, Nath KA, Noseworthy PA (2017) Renal outcomes in anticoagulated patients with atrial fibrillation. J Am Coll Cardiol 70:2621–2632CrossRef
31.
Zurück zum Zitat Hippisley-Cox J, Coupland C (2010) Predicting the risk of chronic Kidney Disease in men and women in England and Wales: prospective derivation and external validation of the QKidney Scores. BMC Fam Pract 11:49CrossRef Hippisley-Cox J, Coupland C (2010) Predicting the risk of chronic Kidney Disease in men and women in England and Wales: prospective derivation and external validation of the QKidney Scores. BMC Fam Pract 11:49CrossRef
32.
Zurück zum Zitat Wetzels JF, Kiemeney LA, Swinkels DW, Willems HL, den Heijer M (2007) Age- and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study. Kidney Int 72:632–637CrossRef Wetzels JF, Kiemeney LA, Swinkels DW, Willems HL, den Heijer M (2007) Age- and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study. Kidney Int 72:632–637CrossRef
33.
Zurück zum Zitat Kuronuma K, Okumura Y, Yokoyama K, Matsumoto N, Tachibana E, Oiwa K, Matsumoto M, Kojima T, Haruta H, Nomoto K, Sonoda K, Arima K, Kogawa R, Takahashi F, Kotani T, Okubo K, Fukushima S, Itou S, Kondo K, Chiku M, Ohno Y, Onikura M, Hirayama A, Investigators ftSAFR (2019) Worsening renal function, adverse clinical events and major determinants for changes of renal function in patients with atrial fibrillation: a Japanese multicenter registry substudy. Curr Med Res Opin 35:2007–2013CrossRef Kuronuma K, Okumura Y, Yokoyama K, Matsumoto N, Tachibana E, Oiwa K, Matsumoto M, Kojima T, Haruta H, Nomoto K, Sonoda K, Arima K, Kogawa R, Takahashi F, Kotani T, Okubo K, Fukushima S, Itou S, Kondo K, Chiku M, Ohno Y, Onikura M, Hirayama A, Investigators ftSAFR (2019) Worsening renal function, adverse clinical events and major determinants for changes of renal function in patients with atrial fibrillation: a Japanese multicenter registry substudy. Curr Med Res Opin 35:2007–2013CrossRef
34.
Zurück zum Zitat Waldum-Grevbo B (2015) What physicians need to know about renal function in outpatients with heart failure. Cardiology 131:130–138CrossRef Waldum-Grevbo B (2015) What physicians need to know about renal function in outpatients with heart failure. Cardiology 131:130–138CrossRef
35.
Zurück zum Zitat van der Aart-van der Beek AB, de Boer RA, Heerspink HJL (2022) Kidney and heart failure outcomes associated with SGLT2 inhibitor use. Nat Rev Nephrol 18:294-306 van der Aart-van der Beek AB, de Boer RA, Heerspink HJL (2022) Kidney and heart failure outcomes associated with SGLT2 inhibitor use. Nat Rev Nephrol 18:294-306
36.
Zurück zum Zitat Banerjee D, Rosano G, Herzog CA (2021) Management of heart failure patient with CKD. Clin J Am Soc Nephrol 16(7):1131–1139CrossRef Banerjee D, Rosano G, Herzog CA (2021) Management of heart failure patient with CKD. Clin J Am Soc Nephrol 16(7):1131–1139CrossRef
37.
Zurück zum Zitat Barrera-Chimal J, Jaisser F (2020) Pathophysiologic mechanisms in diabetic kidney disease: a focus on current and future therapeutic targets. Diabetes Obes Metab 22(Suppl 1):16–31CrossRef Barrera-Chimal J, Jaisser F (2020) Pathophysiologic mechanisms in diabetic kidney disease: a focus on current and future therapeutic targets. Diabetes Obes Metab 22(Suppl 1):16–31CrossRef
38.
Zurück zum Zitat Chen TK, Knicely DH, Grams ME (2019) Chronic kidney disease diagnosis and management: a review. JAMA 322:1294–1304CrossRef Chen TK, Knicely DH, Grams ME (2019) Chronic kidney disease diagnosis and management: a review. JAMA 322:1294–1304CrossRef
39.
Zurück zum Zitat Heerspink HJL, Stefansson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF, Mann JFE, McMurray JJV, Lindberg M, Rossing P, Sjostrom CD, Toto RD, Langkilde AM, Wheeler DC, Committees D-CT, Investigators (2020) Dapagliflozin in patients with chronic kidney disease. N Engl J Med 383:1436–1446CrossRef Heerspink HJL, Stefansson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF, Mann JFE, McMurray JJV, Lindberg M, Rossing P, Sjostrom CD, Toto RD, Langkilde AM, Wheeler DC, Committees D-CT, Investigators (2020) Dapagliflozin in patients with chronic kidney disease. N Engl J Med 383:1436–1446CrossRef
40.
Zurück zum Zitat Ikeda Y, Ishii S, Maemura K, Oki T, Yazaki M, Fujita T, Nabeta T, Maekawa E, Koitabashi T, Ako J (2021) Glucose-dependent diuresis in relation to improvements in renal-tubular markers of sodium-glucose cotransporter-2 inhibitors in hospitalized heart failure patients with diabetes. Heart Vessels 36:978–985CrossRef Ikeda Y, Ishii S, Maemura K, Oki T, Yazaki M, Fujita T, Nabeta T, Maekawa E, Koitabashi T, Ako J (2021) Glucose-dependent diuresis in relation to improvements in renal-tubular markers of sodium-glucose cotransporter-2 inhibitors in hospitalized heart failure patients with diabetes. Heart Vessels 36:978–985CrossRef
41.
Zurück zum Zitat Selvin E, Ning Y, Steffes MW, Bash LD, Klein R, Wong TY, Astor BC, Sharrett AR, Brancati FL, Coresh J (2011) Glycated hemoglobin and the risk of kidney disease and retinopathy in adults with and without diabetes. Diabetes 60:298–305CrossRef Selvin E, Ning Y, Steffes MW, Bash LD, Klein R, Wong TY, Astor BC, Sharrett AR, Brancati FL, Coresh J (2011) Glycated hemoglobin and the risk of kidney disease and retinopathy in adults with and without diabetes. Diabetes 60:298–305CrossRef
42.
Zurück zum Zitat Liao LN, Li CI, Liu CS, Huang CC, Lin WY, Chiang JH, Lin CC, Li TC (2015) Extreme levels of HbA1c increase incident ESRD risk in Chinese patients with type 2 diabetes: competing risk analysis in National Cohort of Taiwan Diabetes Study. PLoS ONE 10:e0130828CrossRef Liao LN, Li CI, Liu CS, Huang CC, Lin WY, Chiang JH, Lin CC, Li TC (2015) Extreme levels of HbA1c increase incident ESRD risk in Chinese patients with type 2 diabetes: competing risk analysis in National Cohort of Taiwan Diabetes Study. PLoS ONE 10:e0130828CrossRef
43.
Zurück zum Zitat Mohanram A, Zhang Z, Shahinfar S, Keane WF, Brenner BM, Toto RD (2004) Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy. Kidney Int 66:1131–1138CrossRef Mohanram A, Zhang Z, Shahinfar S, Keane WF, Brenner BM, Toto RD (2004) Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy. Kidney Int 66:1131–1138CrossRef
44.
Zurück zum Zitat Yahata K, Seta K, Kikuchi Y, Koizumi M, Murata M, Wada H, Murakami S, Ohishi M, Tsuji H, Kyoto Fushimi Renal Anemia study i (2019) Treatment for renal anemia and outcomes in non-dialysis patients with chronic kidney disease: the current status of regional medicine according to the Kyoto Fushimi Renal Anemia (KFRA) study. Clin Exp Nephrol 23:1211–1220CrossRef Yahata K, Seta K, Kikuchi Y, Koizumi M, Murata M, Wada H, Murakami S, Ohishi M, Tsuji H, Kyoto Fushimi Renal Anemia study i (2019) Treatment for renal anemia and outcomes in non-dialysis patients with chronic kidney disease: the current status of regional medicine according to the Kyoto Fushimi Renal Anemia (KFRA) study. Clin Exp Nephrol 23:1211–1220CrossRef
45.
Zurück zum Zitat Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ, Arima H, Chadban SJ, Cirillo M, Djurdjev O, Green JA, Heine GH, Inker LA, Irie F, Ishani A, Ix JH, Kovesdy CP, Marks A, Ohkubo T, Shalev V, Shankar A, Wen CP, de Jong PE, Iseki K, Stengel B, Gansevoort RT, Levey AS (2014) Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA 311:2518–2531CrossRef Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ, Arima H, Chadban SJ, Cirillo M, Djurdjev O, Green JA, Heine GH, Inker LA, Irie F, Ishani A, Ix JH, Kovesdy CP, Marks A, Ohkubo T, Shalev V, Shankar A, Wen CP, de Jong PE, Iseki K, Stengel B, Gansevoort RT, Levey AS (2014) Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA 311:2518–2531CrossRef
46.
Zurück zum Zitat Chang WX, Asakawa S, Toyoki D, Nemoto Y, Morimoto C, Tamura Y, Ota T, Shibata S, Fujigaki Y, Shen ZY, Uchida S (2015) Predictors and the subsequent risk of end-stage renal disease—usefulness of 30% decline in estimated GFR over 2 years. PLoS ONE 10:e0132927CrossRef Chang WX, Asakawa S, Toyoki D, Nemoto Y, Morimoto C, Tamura Y, Ota T, Shibata S, Fujigaki Y, Shen ZY, Uchida S (2015) Predictors and the subsequent risk of end-stage renal disease—usefulness of 30% decline in estimated GFR over 2 years. PLoS ONE 10:e0132927CrossRef
Metadaten
Titel
Characterization of baseline clinical factors associated with incident worsening kidney function in patients with non-valvular atrial fibrillation: the Hokuriku-Plus AF Registry
verfasst von
Kenshi Hayashi
Yoshihiro Tanaka
Toyonobu Tsuda
Akihiro Nomura
Noboru Fujino
Hiroshi Furusho
Norihiko Sakai
Yasunori Iwata
Soichiro Usui
Kenji Sakata
Takeshi Kato
Hayato Tada
Takashi Kusayama
Keisuke Usuda
Masa-aki Kawashiri
Rod S. Passman
Takashi Wada
Masakazu Yamagishi
Masayuki Takamura
the Hokuriku-Plus AF Registry Investigators
Publikationsdatum
17.10.2022
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 3/2023
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-022-02178-w

Weitere Artikel der Ausgabe 3/2023

Heart and Vessels 3/2023 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.